These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38601789)

  • 1. The MIC distribution of dalbavancin differs between different coagulase-negative staphylococci.
    Svensson S; Hagstedt P; Söderquist B
    JAC Antimicrob Resist; 2024 Apr; 6(2):dlae063. PubMed ID: 38601789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial activity of dalbavancin against clinical isolates of coagulase-negative staphylococci from the USA and Europe stratified by species.
    Sader HS; Carvalhaes CG; Streit JM; Arends SJR; Mendes RE
    J Glob Antimicrob Resist; 2021 Mar; 24():48-52. PubMed ID: 33285311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of ceftobiprole and dalbavancin against a collection of coagulase-negative staphylococci isolates from clinical samples with reduced susceptibility to daptomycin and/or resistant to linezolid or glycopeptides.
    Velasco de la Fuente S; Fernández-Martinez M; Rodríguez Lozano J; Pablo-Marcos D; Siller M; Calvo J
    Enferm Infecc Microbiol Clin (Engl Ed); 2023 Nov; 41(9):567-570. PubMed ID: 36707282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial activity of ceftaroline and comparator agents when tested against numerous species of coagulase-negative Staphylococcus causing infection in US hospitals.
    Sader HS; Farrell DJ; Flamm RK; Streit JM; Mendes RE; Jones RN
    Diagn Microbiol Infect Dis; 2016 May; 85(1):80-4. PubMed ID: 26971182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of coagulase-negative staphylococci other than Staphylococcus epidermidis by automated ribotyping.
    Carretto E; Barbarini D; Couto I; De Vitis D; Marone P; Verhoef J; De Lencastre H; Brisse S
    Clin Microbiol Infect; 2005 Mar; 11(3):177-84. PubMed ID: 15715714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species distribution of coagulase negative staphylococci isolated from different clinical specimens.
    Rahman A; Hosaain MA; Mahmud C; Paul SK; Sultana S; Haque N; Kabir MR; Kubayashi N
    Mymensingh Med J; 2012 Apr; 21(2):195-9. PubMed ID: 22561758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of coagulase-negative staphylococci other than S. epidermidis blood stream isolates at a tertiary care hospital.
    Hitzenbichler F; Simon M; Salzberger B; Hanses F
    Infection; 2017 Apr; 45(2):179-186. PubMed ID: 27660064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of tedizolid against clinical isolates of Staphylococcus lugdunensis and Staphylococcus haemolyticus from Europe and the United States.
    Farrell DJ; Mendes RE; Bensaci M
    Diagn Microbiol Infect Dis; 2019 Jan; 93(1):85-88. PubMed ID: 30314652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycopeptide resistance in Enterococcus spp. and coagulase-negative staphylococci from hospitalised patients in Germany: occurrence, characteristics and dalbavancin susceptibility.
    Kresken M; Klare I; Wichelhaus TA; Wohlfarth E; Layer-Nicolaou F; Neumann B; Werner G;
    J Glob Antimicrob Resist; 2022 Mar; 28():102-107. PubMed ID: 34958996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of telavancin and comparator antimicrobial agents tested against Staphylococcus spp. isolated from hospitalised patients in Europe (2007-2008).
    Mendes RE; Sader HS; Jones RN
    Int J Antimicrob Agents; 2010 Oct; 36(4):374-9. PubMed ID: 20598860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic resistance patterns of coagulase-negative staphylococcus strains isolated from blood cultures of septicemic patients in Turkey.
    Koksal F; Yasar H; Samasti M
    Microbiol Res; 2009; 164(4):404-10. PubMed ID: 17475456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Occurrence and Phenotypic Resistance of Coagulase-Negative Staphylococci (CoNS) Found in Human Blood in the Northern Netherlands between 2013 and 2019.
    Berends MS; Luz CF; Ott A; Andriesse GI; Becker K; Glasner C; Friedrich AW
    Microorganisms; 2022 Sep; 10(9):. PubMed ID: 36144403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of Biofilm Formation Properties of Coagulase Negative Staphylococci Isolated from Catheter-Related Bloodstream Infections].
    Öcal D; Tekeli A; Dolapçı İ
    Mikrobiyol Bul; 2022 Jul; 56(3):506-524. PubMed ID: 35960241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of methicillin resistance and macrolide-lincosamide-streptogramin B resistance in
    Teeraputon S; Santanirand P; Wongchai T; Songjang W; Lapsomthob N; Jaikrasun D; Toonkaew S; Tophon P
    New Microbes New Infect; 2017 Sep; 19():28-33. PubMed ID: 28702199
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimicrobial activity of daptomycin in comparison to glycopeptides and other antimicrobials when tested against numerous species of coagulase-negative Staphylococcus.
    Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):212-4. PubMed ID: 22608137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic sensitivities of coagulase-negative staphylococci and
    De Vecchi E; George DA; Romanò CL; Pregliasco FE; Mattina R; Drago L
    Infect Drug Resist; 2018; 11():539-546. PubMed ID: 29695923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulase-negative staphylococci (CoNS) meningitis: a narrative review of the literature from 2000 to 2020.
    Azimi T; Mirzadeh M; Sabour S; Nasser A; Fallah F; Pourmand MR
    New Microbes New Infect; 2020 Sep; 37():100755. PubMed ID: 33014383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species distribution and in vitro antimicrobial susceptibility of coagulase-negative staphylococci isolated from bovine mastitic milk.
    Taponen S; Nykäsenoja S; Pohjanvirta T; Pitkälä A; Pyörälä S
    Acta Vet Scand; 2016 Feb; 58():12. PubMed ID: 26852389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dalbavancin in-vitro activity obtained against Gram-positive clinical isolates causing bone and joint infections in US and European hospitals (2011-2016).
    Pfaller MA; Flamm RK; Castanheira M; Sader HS; Mendes RE
    Int J Antimicrob Agents; 2018 Apr; 51(4):608-611. PubMed ID: 29277526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methicillin and vancomycin resistance in coagulase-negative Staphylococci isolated from the nostrils of hospitalized patients.
    Al-Tamimi M; Abu-Raideh J; Himsawi N; Khasawneh A; Hawamdeh H
    J Infect Dev Ctries; 2020 Jan; 14(1):28-35. PubMed ID: 32088681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.